Form 4: Modular Medical Director Boosts Stake in Public Offering
Insider Transaction Report
Modular Medical Director Steven G. Felsher acquired 60,000 shares of common stock and warrants for 30,000 shares in a public offering.
Summary
- Steven G. Felsher, a Director of Modular Medical, Inc. (MODD), purchased securities on December 11, 2025.
- The acquisition included 60,000 shares of common stock and warrants to purchase an additional 30,000 shares of common stock.
- These securities were acquired through an underwritten public offering.
- The offering price was $0.77 for each unit consisting of two shares of common stock and one warrant.
- Following this transaction, Felsher beneficially owns 253,177 shares of common stock and 30,000 warrants.
- The warrants are immediately exercisable at $0.45 per share and expire on December 11, 2030.
Sentiment
Score: 7
Explanation: The acquisition of a significant number of shares and warrants by a director through a public offering suggests strong insider confidence in the company's future performance and valuation.
Positives
- Insider buying by a Director, Steven G. Felsher, signals confidence in the company's future prospects.
- The acquisition increases the Director's beneficial ownership to 253,177 shares of common stock and 30,000 warrants.
Negatives
- The acquisition was part of an underwritten public offering, which typically involves some level of dilution for existing shareholders.
- The offering price of $0.77 per unit (two shares + one warrant) might be below the market price at the time, potentially indicating a need for capital or a discounted offering to attract investors.
Future Outlook
No specific forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
This insider purchase indicates a director's belief in Modular Medical's future, which can be a positive signal in the medical device or healthcare technology sector, especially for smaller companies seeking to develop and commercialize new products. Such transactions often occur following capital raises to strengthen the balance sheet or fund specific projects.
Related Party Transactions
- This transaction constitutes a related party transaction, as a director (Steven G. Felsher) purchased securities directly from the issuer (Modular Medical, Inc.) as part of a public offering.
Stakeholder Impact
- Shareholders: The public offering likely caused some dilution, but the insider purchase may instill confidence.
- Creditors: The capital raise from the public offering could improve the company's financial position, potentially benefiting creditors.
Next Steps
- The warrants are immediately exercisable, allowing Steven G. Felsher to acquire additional common stock at $0.45 per share at any time before December 11, 2030.
Key Dates
| Date | Description |
|---|---|
| 12/11/2025 | Date of transaction for common stock and warrants acquisition. |
| 12/11/2025 | Warrants became immediately exercisable. |
| 12/15/2025 | Date Form 4 was signed. |
| 12/11/2030 | Warrants expiration date. |
Recommendation
buyThe significant purchase of common stock and warrants by a director, Steven G. Felsher, signals strong insider confidence in Modular Medical, Inc.'s future prospects and valuation. Insider buying is often a bullish indicator, suggesting that those closest to the company believe its shares are undervalued or poised for growth. This action, especially following a public offering, implies a strategic investment by management, warranting a 'buy' recommendation for investors seeking to align with insider sentiment.
Keywords
Modular Medical, MODD, Steven G. Felsher, Insider Buying, Form 4, Common Stock, Warrants, Public Offering, Director, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.